相关实验视频

Updated: Jun 25, 2025

Purification of Hepatocytes and Sinusoidal Endothelial Cells from Mouse Liver Perfusion

Purification of Hepatocytes and Sinusoidal Endothelial Cells from Mouse Liver Perfusion

Published on: February 12, 2018

肝移植或广泛的肝切除术后肝功能障碍的血液净化:远非最佳情景

Rita Gaspari^1,2, Paola Aceto^1,2, Giorgia Spinazzola²

¹Department of Basic Biotechnological Science, Intensive Care and Peri-Operative Clinics, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Journal of clinical medicine

|May 25, 2024

概括

这项研究发现,在肝移植或切除之后,CytoSorb®在肝功能障碍患者中没有改善肝功能. 虽然白血素暂时下降,但它恢复到基线,观察到对血小板和凝血的不良影响.

科学领域:

肝病学肝病学是一种肝病学.
关键护理医学关键护理医学
身体外疗法是一种体外疗法.

背景情况:

肝移植 (LT) 或延长肝切除 (EHR) 后的肝功能障碍 (HD) 会导致移植失败和死亡.
评估CytoSorb®在这些关键环境中净化胆红素的安全性和有效性.
评估对肝脑病变 (HE),SOFA,MELD分数和血液动力学的影响.

研究的目的:

通过测量血清总 bilirubin 的变化来评估 CytoSorb® 的净化疗效.
评估CytoSorb®对肝脑病变 (HE),SOFA,MELD分数和血液动力学状况的影响.

主要方法:

包括在重症监护病房的血清总 bilirubin > 10 mg/dL 的成年患者.
排除标准包括血液动力学不稳定性,出血和血小板数量低 (<20,000/mm3).

主要成果:

在CytoSorb®治疗期间,血清总 bilirubin 降低,但在治疗后的 4/7 个患者中恢复到基线.
血小板数量下降,6名患者需要输血;D-二次体水平增加.
HE,SOFA和MELD得分保持稳定,但血液动力学状况在2名患者中恶化.

结论:

初步研究结果表明,CytoSorb®对LT/EHR后的HD没有持续的临床或实验室益处.
需要进一步的研究来澄清CytoSorb®在治疗严重肝功能障碍中的作用.

关键词:

接种器失效接种器失效血液吸收的吸收方式肝脏功能障碍肝脏功能障碍肝脏切除切除肝脏切除肝脏移植肝脏移植肝脏移植肝脏移植

更多相关视频

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion

Published on: April 27, 2015

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

Published on: November 10, 2011

相关概念视频

Hepatic Drug Excretion: Enterohepatic Cycling

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...